Pregled bibliografske jedinice broj: 897600
Retinoid therapy in the treatment of neuroblastoma
Retinoid therapy in the treatment of neuroblastoma // Proceedings Book
Dubrovnik, Hrvatska: Pharma Publishing and Media Europe, 2016. str. 46-46 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 897600 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Retinoid therapy in the treatment of neuroblastoma
Autori
Skelin, Marko ; Šoškić, Miomir ; Pavela, L ; Radpvoc, A
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Proceedings Book
/ - : Pharma Publishing and Media Europe, 2016, 46-46
Skup
3rd ECOP (European Conference of Oncology Pharmacy)
Mjesto i datum
Dubrovnik, Hrvatska, 19.05.2016. - 21.05.2016
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
neuroblastoma ; retinoids ; paediatric tumours
Sažetak
Neuroblastoma is the most common extracranial solid tumour in child population. This type of tumour is the fourth most abundant of all paediatric tumours. Treatments include combination of surgery, chemotherapy, radiation therapy and stem cell transplant in oncology patients. This survey is conducted in order to determine the most appropriate way of using isotretinoin in patients with neuroblastoma. In children with neuroblastoma this drug can provide significant health benefits when it is used properly. Some adverse reactions of isotretinoin can be very serious and it is important that the child is carefully monitored by parents and his or her physicians and pharmacists together. Pharmacist can have a significant role in supportive treatment of adverse reactions of isotretinoin.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Ustanove:
Opća bolnica Šibenik